July 8, 2013 / 6:42 AM / 4 years ago

Bayer starts clinical of drug for children with haemophilia

FRANKFURT, July 8 (Reuters) - Bayer AG said it had started a late stage clinical trial of its drug BAY 94-9027 for prophylaxis and treatment of bleeding in previously treated children with severe haemophilia A, it said in a statement on Monday. (Reporting by Jonathan Gould; Editing by Christoph Steitz)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below